Sep 17, 2020 - Oxurion NV (OTCPK:TBGNF) Q2 2020 Earnings Conference Call September 17, 2020 12:30 PM ET Company Participants Patrik De Haes - CEO Dominique Vanfleteren - CFO Andy De Deene - CDO Grace Chang - CMO Conference Call Participants Frédéric Gomez - Pharmium Sandra Cauwenberghs - KBC Securities Danny Van Quaethem - Econopolis Presentation Operator Good morning and good afternoon ladies and gentlemen.
Apr 01, 2020 - NVS vs. NVO: Which Stock Is the Better Value Option?
Apr 07, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
Apr 14, 2020 - Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.
Apr 21, 2020 - Novartis (NVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Apr 20, 2020 - Novartis (NVS) announces FDA's approval to evaluate hydroxychloroquine in hospitalized patients with COVID-19 in a late-stage study. The company is evaluating several of its drugs to treat COVID-19.
Apr 21, 2020 - Investor focus is likely to be on the impact of the coronavirus outbreak on Lilly's (LLY) performance when it reports first-quarter results.
Sep 17, 2020 - Top Stock Reports for Novartis, Zoom Video & Caterpillar
Sep 18, 2020 - Ahold NV (ADRNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sep 18, 2020 - The Zacks Analyst Blog Highlights: Novartis, Zoom Video, Caterpillar, Microsoft, Cisco, Clorox and LHC Group